To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ADPRHL2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
381 supporting clones for gene ADPRHL2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_017825.2   .a 1 to 1690 1 to 1690 exact RefSeq, AAA   1690/1690
(100 %)
0 diff
(100 %id)
DC365461   .a 1 to 693 1 to 693   tiling clone,   693/693
(100 %)
5 diff
(99.3 %id)
AF212236 liver cancer .a 3 to 1690 1 to 1687 A3Q A4R A5R M6W A7R ... tiling clone, AAA   1687/1687
(100 %)
16 diff
(99.1 %id)
H83970 eye, retina .a 3 to 246 1 to 246       246/246
(100 %)
8 diff
(96.8 %id)
AA017018 eye, retina .a 3 to 203 1 to 200       200/202
(99 %)
6 diff
(97.1 %id)
DC393538 colon, tumor tissue .a 14 to 563 1 to 550       550/550
(100 %)
1 diff
(99.9 %id)
BM543826 ovary (pool of 3) .a 21 to 753 1 to 738       738/1128
(65 %)
17 diff
(98.5 %id)
BG720830 testis .a 23 to 705 1 to 683       683/687
(99 %)
9 diff
(98.7 %id)
AJ427295   .a 24 to 1690 1 to 1667 exact tiling clone, AAA   1667/1667
(100 %)
0 diff
(100 %id)
DC304612 cerebellum .a 25 to 589 1 to 565       565/565
(100 %)
0 diff
(100 %id)
DC395256 testis .a 25 to 567 1 to 543       543/543
(100 %)
0 diff
(100 %id)
DC296853   .a 26 to 585 1 to 561       561/561
(100 %)
3 diff
(99.5 %id)
BM921026 pooled brain, lung, testis .a 26 to 863 12 to 855       844/1076
(78 %)
21 diff
(98.1 %id)
BP275257 Kidney .a 30 to 611 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA540802 lung .a 32 to 599 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
BP380892   .a 32 to 496 1 to 464       464/464
(100 %)
3 diff
(99.4 %id)
AK000453   .a 34 to 1690 1 to 1657 exact available from FLJ, AAA   1657/1657
(100 %)
1 diff
(100.0 %id)
TI_57171600   .a 34 to 953 31 to 959       927/961
(96 %)
27 diff
(97.2 %id)
DA369246 subthalamic nucleus .a 35 to 596 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
BM918465 pooled pancreas and spleen .a 35 to 1056 1 to 1030       1030/1033
(99 %)
20 diff
(98.1 %id)
BP379545 uterus .a 35 to 603 1 to 569       569/577
(98 %)
1 diff
(99.9 %id)
CR609775 placenta .a 36 to 1599 1 to 1564 exact     1564/1564
(100 %)
0 diff
(100 %id)
AL541484 placenta .a 36 to 856 1 to 821   fully sequenced,   821/821
(100 %)
2 diff
(99.8 %id)
BG705327 brain, hippocampus .a 36 to 781 1 to 744       744/799
(93 %)
10 diff
(98.8 %id)
BI834255 pooled pancreas and spleen .a 36 to 958 1 to 923       923/923
(100 %)
19 diff
(98.0 %id)
TI_57163716   .a 36 to 958 32 to 954       923/954
(96 %)
25 diff
(97.4 %id)
BP272720   .a 37 to 601 1 to 566       566/566
(100 %)
6 diff
(99.0 %id)
BG397224 melanotic melanoma, skin .a 38 to 838 1 to 803       803/806
(99 %)
6 diff
(99.3 %id)
BI828211 brain, medulla .a 38 to 953 1 to 925       923/927
(99 %)
21 diff
(97.8 %id)
BC014169 Skin, melanotic melanoma. .a 39 to 1690 1 to 1652 exact available from MGC, AAA   1652/1652
(100 %)
0 diff
(100 %id)
BX420858 brain, fetal brain .a 39 to 1023 1 to 976       976/976
(100 %)
26 diff
(97.4 %id)
DA845536 placenta .a 39 to 589 2 to 555   capped   554/554
(100 %)
4 diff
(99.3 %id)
CN427353 embryonic stem cells, DMSO-treated H9 cellline .a 40 to 689 1 to 650       650/650
(100 %)
3 diff
(99.6 %id)
BP197646 adrenal gland .a 41 to 624 1 to 582       582/582
(100 %)
5 diff
(99.2 %id)
BP373152 umbilical cord .a 41 to 618 1 to 578       578/578
(100 %)
0 diff
(100 %id)
DA086858 cerebellum .a 42 to 603 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
DA263525 caudate nucleus .a 42 to 589 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA358943 subthalamic nucleus .a 42 to 577 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
DA425841 colon .a 42 to 565 2 to 526   capped   525/525
(100 %)
1 diff
(99.9 %id)
DA512569 brain .a 42 to 509 2 to 470   capped   469/469
(100 %)
3 diff
(99.4 %id)
DA581446 lung .a 42 to 433 2 to 394   capped   393/393
(100 %)
1 diff
(99.8 %id)
DA768671 brain .a 42 to 556 2 to 516   capped   515/515
(100 %)
1 diff
(99.9 %id)
DA837611 placenta .a 42 to 546 2 to 506   capped   505/505
(100 %)
1 diff
(99.9 %id)
DA842920 placenta .a 42 to 615 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA914841   .a 42 to 601 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DA963759 stomach .a 42 to 585 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DB052983 testis .a 42 to 552 2 to 514   capped   513/513
(100 %)
2 diff
(99.7 %id)
DA140755 alzheimer cortex .a 43 to 634 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
DB011541 colon, tumor tissue .a 43 to 634 2 to 595   capped   594/594
(100 %)
2 diff
(99.7 %id)
DA072213 cerebellum .a 44 to 597 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA355921 subthalamic nucleus .a 45 to 614 2 to 571   capped   570/570
(100 %)
5 diff
(99.2 %id)
CR619499 B cells (Ramos cell line) Cot 25-normalized .a 45 to 1654 1 to 1610 exact     1610/1610
(100 %)
0 diff
(100 %id)
AL560709 B cells from Burkitt lymphoma .a 45 to 886 1 to 841   fully sequenced,   841/841
(100 %)
2 diff
(99.8 %id)
DB463900 hippocampus .a 45 to 441 1 to 398       398/403
(98 %)
14 diff
(96.6 %id)
BQ212401 melanotic melanoma, skin .a 45 to 754 8 to 730       723/936
(77 %)
31 diff
(96.7 %id)
BU193025 eye, retinoblastoma .a 45 to 827 8 to 800       790/886
(89 %)
22 diff
(97.6 %id)
TI_57219369   .a 45 to 886 35 to 888       852/890
(95 %)
24 diff
(97.4 %id)
DA910149   .a 45 to 602 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA585393 lung .a 46 to 583 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
BI752365 brain .a 46 to 886 1 to 853       851/855
(99 %)
24 diff
(97.2 %id)
BP274024   .a 46 to 606 1 to 563       563/565
(99 %)
7 diff
(98.8 %id)
BP308202 brain .a 46 to 633 1 to 588       588/588
(100 %)
0 diff
(100 %id)
BP328481 rectum .a 46 to 626 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BP328531 rectum .a 46 to 627 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DR006522 Spleen .a 46 to 603 14 to 571       558/571
(97 %)
10 diff
(98.3 %id)
BI830082 brain, medulla .a 47 to 831 1 to 785       785/785
(100 %)
6 diff
(99.3 %id)
BI752154 brain .a 47 to 782 1 to 735       735/735
(100 %)
3 diff
(99.6 %id)
TI_57215106   .a 47 to 782 30 to 764       735/764
(96 %)
9 diff
(98.9 %id)
TI_57176637   .a 47 to 831 67 to 851       785/851
(92 %)
12 diff
(98.6 %id)
DB034768 testis .a 47 to 583 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
AL558345 T cells from T cell leukemia .a 48 to 820 1 to 773   fully sequenced,   773/773
(100 %)
0 diff
(100 %id)
BI258602 cervical carcinoma cell line, cervix .a 48 to 856 1 to 820       820/896
(91 %)
23 diff
(97.5 %id)
BP370639 testis .a 48 to 636 1 to 588       588/588
(100 %)
11 diff
(98.2 %id)
CR595076 fetal brain .a 49 to 1652 1 to 1604 exact     1604/1604
(100 %)
0 diff
(100 %id)
BX418192 brain, fetal brain .a 49 to 1166 1 to 1105 E209K T279P A280P I281S Y282T ...     1105/1105
(100 %)
19 diff
(98.3 %id)
BX418193 brain, fetal brain .a 49 to 856 1 to 806       806/812
(99 %)
20 diff
(97.6 %id)
BG697042 skin .a 49 to 959 1 to 905       903/906
(99 %)
27 diff
(97.1 %id)
BI761097 pooled colon, kidney, stomach .a 49 to 679 1 to 637       637/659
(96 %)
16 diff
(97.6 %id)
BI488487 brain .a 49 to 908 1 to 865       865/867
(99 %)
14 diff
(98.4 %id)
BI772123 pooled lung and spleen .a 49 to 726 1 to 685       683/685
(99 %)
13 diff
(98.2 %id)
BI768017 pooled lung and spleen .a 49 to 982 1 to 925       925/925
(100 %)
19 diff
(98.0 %id)
BI833294 pooled pancreas and spleen .a 49 to 798 1 to 748       748/748
(100 %)
4 diff
(99.5 %id)
BU858085 adenocarcinoma, cell line, breast .a 49 to 744 57 to 761       705/1036
(68 %)
31 diff
(97.1 %id)
TI_45378969   .a 49 to 908 68 to 932       865/934
(92 %)
22 diff
(97.7 %id)
TI_57146787   .a 49 to 679 31 to 667       637/689
(92 %)
20 diff
(97.1 %id)
TI_57178887   .a 49 to 726 33 to 717       683/717
(95 %)
15 diff
(98.0 %id)
TI_57180381   .a 49 to 952 35 to 930       896/959
(93 %)
23 diff
(97.7 %id)
TI_57181704   .a 49 to 937 29 to 916       888/916
(96 %)
17 diff
(98.2 %id)
TI_57165831   .a 49 to 798 28 to 775       748/775
(96 %)
9 diff
(98.9 %id)
AK223037 thyroid .a 50 to 1690 1 to 1641 E209K AAA   1641/1641
(100 %)
2 diff
(99.9 %id)
BP265372 thyroid .a 50 to 633 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BP366612 thymus .a 50 to 633 1 to 584       584/584
(100 %)
0 diff
(100 %id)
DA357753 subthalamic nucleus .a 51 to 611 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DA428545 colon .a 51 to 615 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
AL544706 placenta, Placenta Cot 25-normalized .a 51 to 862 1 to 812   fully sequenced,   812/812
(100 %)
1 diff
(99.9 %id)
BX402999   .a 51 to 567 1 to 503       503/642
(78 %)
27 diff
(95.8 %id)
BI827642 brain, medulla .a 51 to 845 1 to 811       792/812
(97 %)
33 diff
(96.0 %id)
BI838453 pooled pancreas and spleen .a 51 to 833 1 to 784       784/784
(100 %)
2 diff
(99.8 %id)
BM927590 lymph, lymphoma, cell line .a 51 to 1013 1 to 968       968/1067
(90 %)
28 diff
(97.4 %id)
BQ061378 lymph, lymphoma, cell line .a 51 to 864 1 to 818       818/1055
(77 %)
15 diff
(98.6 %id)
CX783839 human embryonic stem cells .a 51 to 698 1 to 648       648/648
(100 %)
0 diff
(100 %id)
TI_57172009   .a 51 to 845 29 to 839       792/840
(94 %)
35 diff
(95.9 %id)
TI_57163092   .a 51 to 833 66 to 849       784/849
(92 %)
8 diff
(99.1 %id)
CR623438 HeLa cells Cot 25-normalized .a 52 to 1662 1 to 1611 exact     1611/1611
(100 %)
0 diff
(100 %id)
AL557348 T cells (Jurkat cell line), T cells from T cell leukemia .a 52 to 819 1 to 768   fully sequenced,   768/768
(100 %)
0 diff
(100 %id)
AL556688 placenta .a 52 to 820 1 to 772   fully sequenced,   772/772
(100 %)
7 diff
(99.1 %id)
CB996915 placenta, pre-eclamptic placenta .a 52 to 789 28 to 769       740/848
(87 %)
15 diff
(98.3 %id)
TI_57198570   .a 52 to 889 34 to 869       836/870
(96 %)
15 diff
(98.3 %id)
TI_57238003   .a 52 to 894 63 to 906       846/907
(93 %)
26 diff
(97.2 %id)
BP376601 uterus .a 52 to 633 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
DA061433 cerebellum .a 53 to 614 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
AL559601 T cells from T cell leukemia .a 53 to 569 1 to 519       519/806
(64 %)
11 diff
(98.7 %id)
BI770185 pooled lung and spleen .a 53 to 830 1 to 787       786/787
(99 %)
26 diff
(96.7 %id)
TI_57178110   .a 53 to 830 30 to 816       786/816
(96 %)
25 diff
(97.0 %id)
BP332463 renal proximal tubule .a 53 to 569 1 to 517       517/578
(89 %)
19 diff
(96.8 %id)
CR457237   .a 54 to 1143 1 to 1090       1090/1092
(99 %)
2 diff
(99.9 %id)
BM922292 pooled brain, lung, testis .a 54 to 1037 24 to 1016       993/1033
(96 %)
28 diff
(97.3 %id)
BM924548 pooled colon, kidney, stomach .a 54 to 1028 1 to 990       990/1054
(93 %)
20 diff
(98.2 %id)
BI767279 pooled lung and spleen .a 55 to 937 1 to 882       882/882
(100 %)
12 diff
(98.7 %id)
BF685594 leiomyosarcoma cell line, uterus .a 56 to 756 1 to 701       701/947
(74 %)
2 diff
(99.8 %id)
BG829597 epithelioid carcinoma cell line, Pancreas .a 56 to 807 1 to 753       753/753
(100 %)
1 diff
(99.9 %id)
BG830130 epithelioid carcinoma cell line, Pancreas .a 56 to 829 1 to 776       776/776
(100 %)
4 diff
(99.5 %id)
BM471428 leiomyosarcoma, uterus .a 56 to 630 23 to 598       576/1196
(48 %)
15 diff
(98.8 %id)
BU194984 melanotic melanoma, skin .a 56 to 753 10 to 709       700/964
(72 %)
9 diff
(99.1 %id)
CN427351 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 57 to 764 9 to 716       708/716
(98 %)
6 diff
(99.2 %id)
BE384885 melanotic melanoma, skin .a 57 to 756 1 to 708       708/790
(89 %)
14 diff
(98.3 %id)
BE895054 melanotic melanoma, skin .a 57 to 807 1 to 751       751/821
(91 %)
14 diff
(98.3 %id)
BG106632 lymph, lymphoma, cell line .a 57 to 756 1 to 696       696/913
(76 %)
13 diff
(98.6 %id)
BI333177 cervical carcinoma cell line, cervix .a 57 to 952 1 to 892       892/892
(100 %)
12 diff
(98.7 %id)
BI821873 pooled brain, lung, testis .a 57 to 889 1 to 832       832/833
(99 %)
11 diff
(98.7 %id)
BI909865 leukocyte .a 57 to 894 1 to 840       842/841
(100 %)
22 diff
(97.4 %id)
BM544724 brain, hippocampus .a 57 to 764 1 to 710       710/1115
(63 %)
15 diff
(98.7 %id)
BQ067264 pooled brain, lung, testis .a 57 to 1056 26 to 1042       1017/1095
(92 %)
35 diff
(96.9 %id)
BX400231   .a 58 to 1002 1 to 936       936/970
(96 %)
18 diff
(98.2 %id)
BE384941 melanotic melanoma, skin .a 58 to 638 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BE386068 melanotic melanoma, skin .a 58 to 640 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BE384524 melanotic melanoma, skin .a 58 to 695 1 to 634       634/636
(99 %)
5 diff
(99.3 %id)
BE869197 adenocarcinoma, colon .a 58 to 752 1 to 698       698/1060
(65 %)
7 diff
(99.4 %id)
BG740569 skin .a 58 to 801 1 to 746       746/746
(100 %)
6 diff
(99.2 %id)
CR600346 Neuroblastoma Cot 25-normalized .a 59 to 1654 1 to 1596       1596/1596
(100 %)
0 diff
(100 %id)
AL519510 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 59 to 511 1 to 452       452/452
(100 %)
11 diff
(97.6 %id)
BX344796 Neuroblastoma Cot 10-normalized .a 59 to 843 1 to 784       784/784
(100 %)
35 diff
(95.6 %id)
AL528040 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 59 to 820 1 to 762   fully sequenced,   762/762
(100 %)
11 diff
(98.6 %id)
BI488720 brain .a 59 to 842 1 to 782       782/783
(99 %)
6 diff
(99.3 %id)
BM924246 pooled colon, kidney, stomach .a 59 to 997 14 to 953       940/1074
(87 %)
19 diff
(98.3 %id)
TI_45379422   .a 59 to 842 67 to 848       782/849
(92 %)
12 diff
(98.6 %id)
BP272544   .a 60 to 639 1 to 582       582/585
(99 %)
20 diff
(96.6 %id)
BP272605   .a 60 to 622 1 to 563       563/563
(100 %)
3 diff
(99.5 %id)
BP296281   .a 60 to 621 1 to 562       562/562
(100 %)
1 diff
(99.9 %id)
AA112451 Pancreas .a 61 to 420 10 to 383       372/383
(97 %)
21 diff
(94.6 %id)
BF525882 brain, glioblastoma with EGFR amplification .a 61 to 799 1 to 737       737/738
(99 %)
16 diff
(97.9 %id)
CX758256 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 61 to 757 1 to 697     Submitted on the opposite strand 697/701
(99 %)
2 diff
(99.8 %id)
CB594831 Blood, promyelocytic leukemia .a 61 to 939 1 to 889       889/957
(92 %)
12 diff
(98.8 %id)
BI754686 brain .a 63 to 1006 1 to 949       893/962
(92 %)
25 diff
(97.5 %id)
TI_57217386   .a 63 to 843 34 to 814       781/995
(78 %)
11 diff
(98.9 %id)
BM560280 brain, medulla .a 64 to 1004 12 to 962       951/1010
(94 %)
43 diff
(95.8 %id)
CR621192 B cells (Ramos cell line) Cot 25-normalized .a 65 to 1654 1 to 1590       1590/1590
(100 %)
0 diff
(100 %id)
AL561443 B cells from Burkitt lymphoma .a 65 to 886 1 to 821   fully sequenced,   821/821
(100 %)
1 diff
(99.9 %id)
CA454467   .a 65 to 863 1 to 804       802/899
(89 %)
8 diff
(99.2 %id)
DA067723 cerebellum .a 66 to 636 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DB047209 testis .a 66 to 621 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
BM468061 leiomyosarcoma, uterus .a 67 to 997 1 to 941       941/1033
(91 %)
27 diff
(97.4 %id)
TI_57218159   .a 67 to 931 27 to 894       868/898
(96 %)
15 diff
(98.4 %id)
CR594747 fetal liver .a 73 to 1663 1 to 1591       1591/1591
(100 %)
0 diff
(100 %id)
CR604004 fetal liver .a 73 to 1653 1 to 1581       1581/1581
(100 %)
0 diff
(100 %id)
BX444118 fetal liver, Liver .a 73 to 820 1 to 748   fully sequenced,   748/748
(100 %)
2 diff
(99.8 %id)
BX405997 fetal liver, Liver .a 73 to 990 1 to 902   fully sequenced,   902/902
(100 %)
7 diff
(99.3 %id)
BI752407 brain .a 73 to 931 1 to 862       862/866
(99 %)
11 diff
(98.8 %id)
CR619091 HeLa cells Cot 25-normalized .a 74 to 1662 1 to 1589       1589/1589
(100 %)
0 diff
(100 %id)
AL556717 placenta .a 74 to 820 1 to 747   fully sequenced,   747/747
(100 %)
0 diff
(100 %id)
BM903706 ovary (pool of 3) .a 74 to 869 14 to 807       794/1068
(74 %)
16 diff
(98.6 %id)
BE733852 choriocarcinoma, placenta .a 76 to 814 1 to 738       738/740
(99 %)
4 diff
(99.5 %id)
BE293057 adenocarcinoma cell line, colon .a 77 to 765 1 to 679       679/730
(93 %)
14 diff
(98.1 %id)
CN427348 embryonic stem cells, DMSO-treated H9 cellline .a 80 to 732 1 to 653       653/653
(100 %)
0 diff
(100 %id)
BE304714 adenocarcinoma cell line, colon .a 84 to 650 1 to 564       564/566
(99 %)
16 diff
(97.2 %id)
BM017107 astrocytoma grade IV, cell line, brain .a 84 to 831 1 to 755       733/755
(97 %)
20 diff
(97.4 %id)
BM019933 astrocytoma grade IV, cell line, brain .a 84 to 841 1 to 765       765/799
(95 %)
26 diff
(96.8 %id)
BM560302 astrocytoma grade IV, cell line, brain .a 84 to 1033 25 to 993       969/1104
(87 %)
40 diff
(96.4 %id)
TI_59387340   .a 84 to 831 94 to 848       733/755
(97 %)
20 diff
(97.4 %id)
TI_59390708   .a 84 to 841 102 to 866       765/799
(95 %)
26 diff
(96.8 %id)
CR593151 B cells (Ramos cell line) Cot 25-normalized .a 92 to 1661 1 to 1570       1570/1570
(100 %)
0 diff
(100 %id)
AL583407 B cells from Burkitt lymphoma .a 92 to 820 1 to 729   fully sequenced,   729/729
(100 %)
0 diff
(100 %id)
CR613086 B cells (Ramos cell line) Cot 25-normalized .a 102 to 1666 1 to 1565       1565/1565
(100 %)
0 diff
(100 %id)
AL561092 B cells from Burkitt lymphoma .a 103 to 820 1 to 718   fully sequenced,   718/718
(100 %)
9 diff
(98.8 %id)
BQ949978 epidermoid carcinoma, cell line, lung .a 103 to 987 1 to 888       888/889
(99 %)
9 diff
(99.0 %id)
BQ922408 epidermoid carcinoma, cell line, lung .a 103 to 1023 1 to 933       933/943
(98 %)
12 diff
(98.8 %id)
CN427352 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 109 to 485 1 to 377       377/377
(100 %)
1 diff
(99.8 %id)
CD628655   .a 117 to 786 680 to 16       665/697
(95 %)
16 diff
(97.8 %id)
CD628654   .a 151 to 785 1 to 636       636/643
(98 %)
10 diff
(98.5 %id)
EH306748   .a 213 to 264 1 to 52       52/52
(100 %)
0 diff
(100 %id)
BQ722632 sympathetic trunk .a 220 to 997 1 to 784       784/964
(81 %)
22 diff
(97.8 %id)
BP268449 thyroid .a 242 to 823 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BP268889 thyroid .a 242 to 816 1 to 575       575/575
(100 %)
1 diff
(99.9 %id)
CR607590 HeLa cells Cot 25-normalized .a 265 to 1642 1 to 1378       1378/1378
(100 %)
0 diff
(100 %id)
CN427349 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 293 to 923 1 to 633       633/633
(100 %)
2 diff
(99.7 %id)
AA324984 brain, cerebellum .a 309 to 510 1 to 202       202/202
(100 %)
0 diff
(100 %id)
BX383996   .a 352 to 886 250 to 784   fully sequenced,   535/784
(68 %)
11 diff
(98.6 %id)
BG341290 B-cells, primary B-cells from tonsils (cell line) .a 352 to 1126 1 to 772       772/958
(80 %)
35 diff
(96.4 %id)
BG684205 B-cells, primary B-cells from tonsils (cell line) .a 352 to 1058 1 to 707       707/707
(100 %)
2 diff
(99.8 %id)
AV688782 hepatocellular carcinoma .a 361 to 794 1 to 431       431/439
(98 %)
9 diff
(98.0 %id)
BQ268147 insulinoma, Pancreas .a 363 to 832 8 to 477       470/477
(98 %)
6 diff
(98.8 %id)
CB154829 brain .a 364 to 731 1 to 368       368/368
(100 %)
1 diff
(99.8 %id)
CN427350 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 376 to 939 1 to 564       564/564
(100 %)
5 diff
(99.2 %id)
BX092152 senescent fibroblast .a 382 to 1111 1 to 730       730/730
(100 %)
0 diff
(100 %id)
W24239 senescent fibroblast .a 382 to 813 1 to 436       434/436
(99 %)
10 diff
(97.8 %id)
AL561036 B cells from Burkitt lymphoma .a 432 to 886 383 to 838   fully sequenced,   454/460
(98 %)
12 diff
(97.4 %id)
EH350223   .a 445 to 503 1 to 59       59/59
(100 %)
1 diff
(98.4 %id)
BG680528 skin, squamous cell carcinoma .a 458 to 1272 1 to 815       815/815
(100 %)
2 diff
(99.8 %id)
CX781598 human embryonic stem cells .a 485 to 1231 1 to 747   fully sequenced,   747/747
(100 %)
0 diff
(100 %id)
BQ719212 sympathetic trunk .a 562 to 1345 1 to 791       791/966
(81 %)
34 diff
(96.5 %id)
BG324112 Kidney, renal cell adenocarcinoma .a 565 to 1326 1 to 757       757/936
(80 %)
21 diff
(97.8 %id)
BG419444 Kidney, renal cell adenocarcinoma .a 565 to 1310 1 to 744       744/856
(86 %)
13 diff
(98.5 %id)
BG424271 Kidney, renal cell adenocarcinoma .a 565 to 1324 1 to 751       751/847
(88 %)
18 diff
(97.9 %id)
BX418191 brain, fetal brain .a 570 to 1652 1077 to 1       1077/1077
(100 %)
21 diff
(98.1 %id)
AW175671 breast .a 591 to 744 1 to 155       155/155
(100 %)
7 diff
(95.5 %id)
AA857465 colon, colon tumor .a 603 to 1130 1 to 528     Submitted on the opposite strand 528/528
(100 %)
3 diff
(99.5 %id)
DB503167 hypothalamus .a 611 to 1081 1 to 471       471/471
(100 %)
3 diff
(99.4 %id)
DB503177 hypothalamus .a 611 to 1085 1 to 475       475/475
(100 %)
2 diff
(99.6 %id)
AW175811 breast .a 624 to 828 1 to 205       205/205
(100 %)
8 diff
(96.1 %id)
BE787181 large cell carcinoma, lung .a 628 to 1370 1 to 742       742/749
(99 %)
15 diff
(98.0 %id)
BX363680   .a 635 to 1653 1017 to 1       1017/1017
(100 %)
38 diff
(96.3 %id)
BG253407 adenocarcinoma, cell line, Liver .a 641 to 1422 1 to 779       779/944
(82 %)
10 diff
(99.0 %id)
BE383285 brain, neuroblastoma .a 651 to 1356 1 to 702       702/707
(99 %)
9 diff
(98.8 %id)
BE895664 melanotic melanoma, skin .a 653 to 1361 1 to 712       712/724
(98 %)
10 diff
(98.7 %id)
BF686418 leiomyosarcoma cell line, uterus .a 672 to 1481 1 to 807       807/882
(91 %)
32 diff
(96.4 %id)
BE886818 leiomyosarcoma, uterus .a 673 to 1415 1 to 740       740/867
(85 %)
10 diff
(98.9 %id)
BM707148 eye, eye anterior segment .a 673 to 1209 9 to 545   fully sequenced,   537/545
(98 %)
2 diff
(99.7 %id)
N39750 placenta .a 680 to 1172 1 to 493       493/495
(99 %)
1 diff
(99.8 %id)
BM794024 Ascites, stomach .a 692 to 1272 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BM852995 Ascites, stomach .a 692 to 1053 1 to 362       362/362
(100 %)
3 diff
(99.2 %id)
FN129655 breast carcinoma .a 696 to 790 99 to 1     Submitted on the opposite strand 99/105
(94 %)
7 diff
(93.4 %id)
BM691640 eye, RPE and Choroid .a 717 to 1221 1 to 505   fully sequenced,   505/505
(100 %)
2 diff
(99.7 %id)
T97405 liver and spleen .a 719 to 981 1 to 265       265/270
(98 %)
4 diff
(98.6 %id)
BE829240 lung_tumor .a 749 to 1141 30 to 420       391/420
(93 %)
6 diff
(98.6 %id)
BE408732 choriocarcinoma, placenta .a 749 to 1415 7 to 671       665/679
(97 %)
10 diff
(98.6 %id)
BM711889 eye, human retina .a 775 to 1122 1 to 348   fully sequenced,   348/348
(100 %)
1 diff
(99.8 %id)
BM706589 eye, eye anterior segment .a 779 to 1292 9 to 522       514/522
(98 %)
0 diff
(100 %id)
BM823488 Ascites, stomach .a 781 to 1360 1 to 580       580/580
(100 %)
0 diff
(100 %id)
AL579402 T cells (Jurkat cell line), T cells from T cell leukemia .a 789 to 1375 597 to 11   fully sequenced,   587/597
(98 %)
0 diff
(100 %id)
AL528039 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 790 to 1654 862 to 1   fully sequenced,   862/862
(100 %)
7 diff
(99.2 %id)
AL558344 T cells from T cell leukemia .a 790 to 1278 873 to 384   fully sequenced,   490/490
(100 %)
3 diff
(99.4 %id)
AL578915 placenta .a 790 to 1662 872 to 1   fully sequenced,   872/872
(100 %)
4 diff
(99.6 %id)
AL556687 placenta .a 790 to 1662 874 to 1   fully sequenced,   874/874
(100 %)
2 diff
(99.8 %id)
AL582495 B cells from Burkitt lymphoma .a 790 to 1666 876 to 1   fully sequenced,   876/876
(100 %)
5 diff
(99.5 %id)
AL583356 B cells from Burkitt lymphoma .a 790 to 1661 871 to 1   fully sequenced,   871/871
(100 %)
6 diff
(99.4 %id)
BX444117 fetal liver, Liver .a 790 to 1653 864 to 1   fully sequenced,   864/864
(100 %)
5 diff
(99.5 %id)
AA374813 lung .a 807 to 1066 1 to 263       263/300
(87 %)
10 diff
(96.7 %id)
AL568930 placenta .a 825 to 1599 775 to 1   fully sequenced,   775/775
(100 %)
44 diff
(94.4 %id)
BX383995   .a 825 to 1642 817 to 1   fully sequenced,   817/817
(100 %)
43 diff
(94.8 %id)
AL560708 B cells from Burkitt lymphoma .a 825 to 1654 830 to 1   fully sequenced,   830/830
(100 %)
3 diff
(99.7 %id)
AL582341 B cells from Burkitt lymphoma .a 825 to 1619 829 to 32   fully sequenced,   798/829
(96 %)
1 diff
(99.9 %id)
AL561419 B cells from Burkitt lymphoma .a 825 to 1654 831 to 1   fully sequenced,   831/831
(100 %)
3 diff
(99.7 %id)
AL570741 placenta, Placenta Cot 25-normalized .a 847 to 1618 788 to 12   fully sequenced,   777/788
(98 %)
0 diff
(100 %id)
BX352255.
matches multiple genes
  .a 854 to 1689 839 to 1     also hits gene THYN1 839/931
(90 %)
22 diff
(97.7 %id)
AL519509 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 858 to 1661 811 to 11       801/811
(98 %)
0 diff
(100 %id)
AA328958   .a 882 to 1255 1 to 378       378/385
(98 %)
9 diff
(97.7 %id)
CD628652   .a 910 to 1273 379 to 17       363/379
(95 %)
0 diff
(100 %id)
CD628653   .a 910 to 1275 1 to 366       366/384
(95 %)
1 diff
(99.8 %id)
BQ582170 insulinoma, Pancreas .a 914 to 1529 1 to 616     Submitted on the opposite strand 616/616
(100 %)
0 diff
(100 %id)
BU786852 insulinoma, Pancreas .a 915 to 1520 1 to 606     Submitted on the opposite strand 606/606
(100 %)
0 diff
(100 %id)
BE829257 lung_tumor .a 921 to 1327 414 to 10       405/414
(97 %)
0 diff
(100 %id)
TI_154034434   .a 922 to 1690 841 to 80   AAA   762/920
(82 %)
12 diff
(98.7 %id)
W80652 heart .a 928 to 1309 1 to 379   fully sequenced,   379/379
(100 %)
5 diff
(98.7 %id)
TI_149298505   .a 943 to 1690 821 to 85   AAA   737/800
(92 %)
29 diff
(96.4 %id)
BQ018618 lung, Metastatic Chondrosarcoma .a 955 to 1690 754 to 19   AAA   736/736
(100 %)
2 diff
(99.8 %id)
BX405996 fetal liver, Liver .a 960 to 1662 703 to 1   fully sequenced,   703/703
(100 %)
13 diff
(98.2 %id)
BE829321 lung_tumor .a 963 to 1317 356 to 1       356/356
(100 %)
5 diff
(98.6 %id)
BE887094 leiomyosarcoma, uterus .a 965 to 1690 1 to 742       742/800
(92 %)
33 diff
(95.9 %id)
CA313738 Human Lung Epithelial cells, lung .a 995 to 1690 714 to 19   AAA   696/696
(100 %)
0 diff
(100 %id)
CA443538 lung, Metastatic Chondrosarcoma .a 995 to 1690 715 to 19   AAA   697/697
(100 %)
1 diff
(99.9 %id)
BF973162 leiomyosarcoma cell line, uterus .a 1000 to 1695 1 to 712       712/847
(84 %)
26 diff
(97.0 %id)
TI_151766271   .a 1005 to 1688 100 to 783   AAA   684/684
(100 %)
17 diff
(97.6 %id)
BF237935 leiomyosarcoma cell line, uterus .a 1021 to 1522 1 to 509       509/772
(65 %)
15 diff
(98.1 %id)
BX402998   .a 1051 to 1581 533 to 6       528/692
(76 %)
0 diff
(100 %id)
BU626112 cell lines, Enchondroma .a 1053 to 1683 649 to 19   AAA   631/635
(99 %)
2 diff
(99.7 %id)
TI_149308403   .a 1073 to 1690 711 to 93   AAA   619/962
(64 %)
2 diff
(99.8 %id)
BM979615 lung, Primary Lung Epithelial Cells .a 1073 to 1690 637 to 19   AAA   619/627
(98 %)
2 diff
(99.7 %id)
TI_57150892   .a 1086 to 1690 28 to 632   AAA   605/632
(95 %)
6 diff
(99.1 %id)
BI762517 pooled colon, kidney, stomach .a 1091 to 1690 1 to 600   AAA   600/600
(100 %)
0 diff
(100 %id)
BM665697 eye, human retina .a 1092 to 1690 616 to 19   fully sequenced, AAA   598/598
(100 %)
1 diff
(99.9 %id)
BE515180 endometrium, adenocarcinoma cell line, uterus .a 1095 to 1680 8 to 594       587/612
(95 %)
9 diff
(98.6 %id)
BI489550 brain .a 1095 to 1639 546 to 1       546/546
(100 %)
6 diff
(99.0 %id)
TI_45379424   .a 1095 to 1639 546 to 1       546/546
(100 %)
6 diff
(99.0 %id)
AA346711 heart .a 1107 to 1374 1 to 269       269/269
(100 %)
1 diff
(99.7 %id)
BX374258   .a 1107 to 1680 585 to 9       577/787
(73 %)
0 diff
(100 %id)
AA010541 heart .a 1107 to 1517 1 to 422   fully sequenced,   422/422
(100 %)
16 diff
(96.3 %id)
AI590714 normal gingiva (cell line from immortalizedkeratinocytes) .a 1118 to 1685 568 to 1       568/568
(100 %)
1 diff
(99.9 %id)
BQ267891 insulinoma, Pancreas .a 1131 to 1690 575 to 16   AAA   560/560
(100 %)
0 diff
(100 %id)
AA327220 colon .a 1136 to 1286 1 to 151       151/151
(100 %)
0 diff
(100 %id)
EC575194 Prostate .a 1148 to 1241 16 to 110       95/110
(86 %)
6 diff
(94.6 %id)
AI567088 ovary, tumor, 5 pooled (see description) .a 1155 to 1688 534 to 1       534/534
(100 %)
0 diff
(100 %id)
BQ083159 Ascites, stomach .a 1156 to 1364 1 to 209       209/209
(100 %)
3 diff
(98.6 %id)
BU073410 insulinoma, Pancreas .a 1170 to 1695 527 to 2       526/527
(99 %)
0 diff
(100 %id)
Z19489 leg muscle, skeletal muscle .a 1174 to 1508 1 to 338       338/339
(99 %)
10 diff
(97.1 %id)
BM673185 eye, eye anterior segment .a 1179 to 1690 530 to 19   fully sequenced, AAA   512/512
(100 %)
0 diff
(100 %id)
AI360136 anaplastic oligodendroglioma, brain .a 1192 to 1690 499 to 1       499/499
(100 %)
0 diff
(100 %id)
BQ029870 lung, Metastatic Chondrosarcoma .a 1193 to 1690 516 to 19   AAA   498/498
(100 %)
1 diff
(99.8 %id)
BM983234 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 1193 to 1690 515 to 19   AAA   497/497
(100 %)
1 diff
(99.8 %id)
AI803413   .a 1194 to 1683 500 to 11   AAA   490/490
(100 %)
0 diff
(100 %id)
CX781535 human embryonic stem cells .a 1201 to 1697 517 to 21   fully sequenced,   497/517
(96 %)
8 diff
(98.5 %id)
DC426241   .a 1202 to 1690 490 to 1       490/490
(100 %)
18 diff
(96.4 %id)
AA017733 eye, retina .a 1207 to 1691 492 to 3       490/492
(99 %)
0 diff
(100 %id)
N26305 placenta .a 1212 to 1690 483 to 1       483/483
(100 %)
4 diff
(99.2 %id)
BM662270 eye, RPE and Choroid .a 1213 to 1690 495 to 18   fully sequenced, AAA   478/478
(100 %)
0 diff
(100 %id)
BG059784 brain, glioblastoma without EGFR amplification .a 1215 to 1683 469 to 1       469/469
(100 %)
2 diff
(99.6 %id)
W32313 heart .a 1228 to 1672 1 to 461   fully sequenced,   461/461
(100 %)
15 diff
(96.8 %id)
AA862171 squamous cell carcinoma from base of tongue, tongue .a 1228 to 1684 457 to 1       457/457
(100 %)
2 diff
(99.6 %id)
DB574384 hypothalamus .a 1230 to 1690 1 to 461     Submitted on the opposite strand 461/462
(99 %)
1 diff
(99.8 %id)
F34822 pectoral muscle (after mastectomy) .a 1234 to 1519 1 to 286       286/286
(100 %)
2 diff
(99.4 %id)
AI096377 heart .a 1241 to 1691 451 to 1       451/451
(100 %)
0 diff
(100 %id)
AI362732 anaplastic oligodendroglioma, brain .a 1242 to 1690 449 to 1       449/449
(100 %)
0 diff
(100 %id)
BQ015768 lung, Metastatic Chondrosarcoma .a 1242 to 1690 468 to 19   AAA   450/450
(100 %)
8 diff
(98.3 %id)
AI421094 brain, glioblastoma (pooled) .a 1245 to 1690 446 to 1       446/446
(100 %)
0 diff
(100 %id)
BF095486 uterus_tumor .a 1249 to 1570 322 to 1       322/322
(100 %)
0 diff
(100 %id)
AA481897 ovarian tumor, ovary .a 1249 to 1656 1 to 408       408/408
(100 %)
2 diff
(99.6 %id)
AA703669   .a 1254 to 1691 447 to 9     Submitted on the opposite strand 439/447
(98 %)
0 diff
(100 %id)
BI192960 epithelioid carcinoma cell line, Pancreas .a 1255 to 1690 1 to 434   AAA   434/434
(100 %)
2 diff
(99.6 %id)
AA112281 Pancreas .a 1271 to 1691 426 to 4       423/429
(98 %)
0 diff
(100 %id)
AA702862 liver and spleen .a 1273 to 1683 410 to 1       410/410
(100 %)
3 diff
(99.3 %id)
AI274872 adenocarcinoma, colon .a 1277 to 1690 426 to 13   AAA   414/414
(100 %)
1 diff
(99.8 %id)
AW075400 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .a 1277 to 1690 413 to 1       413/413
(100 %)
1 diff
(99.8 %id)
R71684 breast .a 1278 to 1690 419 to 1       419/428
(97 %)
16 diff
(96.3 %id)
W80653 heart .a 1279 to 1690 412 to 1   fully sequenced,   412/412
(100 %)
0 diff
(100 %id)
BI003622 head_normal .a 1280 to 1556 297 to 21       277/297
(93 %)
0 diff
(100 %id)
AI536843 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 1281 to 1691 417 to 7       411/417
(98 %)
0 diff
(100 %id)
AA740197 2 pooled tumors (clear cell type), Kidney .a 1289 to 1691 405 to 3       403/405
(99 %)
0 diff
(100 %id)
AW967450   .a 1294 to 1689 396 to 1     Submitted on the opposite strand 396/584
(67 %)
0 diff
(100 %id)
AA251170 germinal center B cell .a 1294 to 1682 1 to 387       387/387
(100 %)
2 diff
(99.5 %id)
AI961718 thymus, pooled .a 1298 to 1684 387 to 1       387/387
(100 %)
0 diff
(100 %id)
TI_57150412   .a 1301 to 1690 30 to 415   AAA   386/415
(93 %)
6 diff
(98.6 %id)
AL581206 T cells from T cell leukemia .a 1302 to 1655 356 to 1       356/356
(100 %)
6 diff
(98.4 %id)
BI762749 pooled colon, kidney, stomach .a 1302 to 1690 1 to 385   AAA   385/385
(100 %)
6 diff
(98.5 %id)
BU781721 insulinoma, Pancreas .a 1303 to 1690 392 to 5     Submitted on the opposite strand 388/392
(98 %)
0 diff
(100 %id)
AI919251   .a 1311 to 1691 389 to 9       381/389
(97 %)
0 diff
(100 %id)
AI249486 lymph node, lymphoma, follicular mixed small and largecell .a 1312 to 1691 381 to 2       380/381
(99 %)
0 diff
(100 %id)
AI867003 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 1317 to 1690 374 to 1       374/374
(100 %)
0 diff
(100 %id)
AA251118 germinal center B cell .a 1318 to 1691 379 to 6     Submitted on the opposite strand 374/379
(98 %)
0 diff
(100 %id)
AW196281 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1319 to 1691 376 to 4       373/376
(99 %)
0 diff
(100 %id)
AW294277   .a 1330 to 1690 378 to 18   AAA   361/361
(100 %)
0 diff
(100 %id)
BU732293 eye, RPE and Choroid .a 1330 to 1690 379 to 19   AAA   361/361
(100 %)
1 diff
(99.8 %id)
BU949160 Pancreas, Purified pancreatic islet .a 1337 to 1691 360 to 6       355/360
(98 %)
0 diff
(100 %id)
AA134305   .a 1339 to 1688 1 to 350   fully sequenced,   350/350
(100 %)
5 diff
(98.6 %id)
DB512789 testis .a 1340 to 1690 1 to 353     Submitted on the opposite strand 353/353
(100 %)
12 diff
(96.7 %id)
H83971 eye, retina .a 1344 to 1671 333 to 1       333/356
(93 %)
11 diff
(97.0 %id)
AA922297 adenocarcinoma, colon .a 1347 to 1690 354 to 11   AAA   344/344
(100 %)
0 diff
(100 %id)
BI838632 pooled pancreas and spleen .a 1359 to 1691 1 to 335       335/367
(91 %)
5 diff
(98.7 %id)
AW000803 colon, colonic mucosa from 3 patients with Crohn'sdisease .a 1365 to 1690 346 to 21   AAA   326/326
(100 %)
2 diff
(99.4 %id)
R68109 placenta .a 1367 to 1691 325 to 1       325/325
(100 %)
2 diff
(99.4 %id)
AA954001 2 pooled tumors (clear cell type), Kidney .a 1367 to 1690 324 to 1       324/324
(100 %)
0 diff
(100 %id)
BP388839 pancreatic islet .a 1372 to 1691 1 to 320     Submitted on the opposite strand 320/325
(98 %)
1 diff
(99.7 %id)
BG957821 colon .a 1375 to 1477 105 to 6       100/105
(95 %)
0 diff
(100 %id)
DB574396 hypothalamus .a 1385 to 1689 1 to 305     Submitted on the opposite strand 305/307
(99 %)
5 diff
(98.4 %id)
AA016266 eye, retina .a 1394 to 1691 301 to 3       299/301
(99 %)
0 diff
(100 %id)
W02125 heart .a 1397 to 1684 293 to 1   fully sequenced,   293/293
(100 %)
1 diff
(99.7 %id)
AA134306   .a 1398 to 1691 294 to 1   fully sequenced,   294/294
(100 %)
0 diff
(100 %id)
F30628 pectoral muscle (after mastectomy) .a 1402 to 1690 1 to 289       289/289
(100 %)
4 diff
(98.7 %id)
CA309739 Alveolar Macrophage, lung .a 1402 to 1690 307 to 19   AAA   289/289
(100 %)
0 diff
(100 %id)
T97291 liver and spleen .a 1405 to 1691 294 to 4       291/294
(98 %)
0 diff
(100 %id)
AI609193 brain, tumor, 5 pooled (see description) .a 1405 to 1683 304 to 26   AAA   279/279
(100 %)
1 diff
(99.7 %id)
BM979254 lung, Primary Lung Epithelial Cells .a 1408 to 1690 302 to 19   AAA   284/284
(100 %)
2 diff
(99.3 %id)
AI872771 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 1409 to 1690 294 to 13   AAA   282/282
(100 %)
2 diff
(99.3 %id)
AI953469 normal epithelium, ovary .a 1410 to 1690 281 to 1       281/281
(100 %)
0 diff
(100 %id)
AI280666 ovary, tumor, 5 pooled (see description) .a 1411 to 1691 281 to 1       281/281
(100 %)
0 diff
(100 %id)
AI142609 pooled .a 1412 to 1691 282 to 3       280/282
(99 %)
0 diff
(100 %id)
AW292914   .a 1413 to 1666 10 to 263     Submitted on the opposite strand 254/272
(93 %)
2 diff
(99.3 %id)
BQ335048 marrow .a 1417 to 1688 283 to 6       278/283
(98 %)
0 diff
(100 %id)
BP386607 pancreatic islet .a 1423 to 1655 1 to 233     Submitted on the opposite strand 233/233
(100 %)
0 diff
(100 %id)
BE122665 skin .a 1429 to 1665 237 to 1     Submitted on the opposite strand 237/237
(100 %)
0 diff
(100 %id)
AW591529 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1430 to 1690 261 to 1       261/261
(100 %)
2 diff
(99.3 %id)
AA644482 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1432 to 1691 264 to 5       260/264
(98 %)
0 diff
(100 %id)
AA746091 Kidney .a 1436 to 1691 263 to 8       256/263
(97 %)
0 diff
(100 %id)
AI471178 brain, glioblastoma (pooled) .a 1437 to 1690 254 to 1       254/254
(100 %)
0 diff
(100 %id)
AI540437 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1437 to 1691 262 to 9       254/262
(96 %)
0 diff
(100 %id)
AI802414   .a 1460 to 1691 240 to 9       232/240
(96 %)
0 diff
(100 %id)
AA010542 heart .a 1487 to 1693 210 to 1   fully sequenced,   210/210
(100 %)
2 diff
(99.1 %id)
EC561461 Prostate .a 1518 to 1609 1 to 93       93/93
(100 %)
7 diff
(92.5 %id)
EC494239 Prostate .a 1521 to 1610 1 to 90       90/90
(100 %)
5 diff
(94.5 %id)
AW874228 follicular carcinoma, thyroid .a 1546 to 1690 159 to 15   AAA   145/145
(100 %)
1 diff
(99.4 %id)
BQ017068 lung, Metastatic Chondrosarcoma .a 1557 to 1690 152 to 19   AAA   134/134
(100 %)
0 diff
(100 %id)
C01955   .a 1603 to 1690 1 to 88       88/88
(100 %)
0 diff
(100 %id)
AI310970 2 pooled tumors (clear cell type), Kidney .a 1607 to 1691 88 to 4       85/93
(91 %)
0 diff
(100 %id)
BE876362 large cell carcinoma, undifferentiated, lung .a 1610 to 1685 1 to 76       76/76
(100 %)
0 diff
(100 %id)
BP199846 brain .b 1 to 582 1 to 582   tiling clone,   582/582
(100 %)
2 diff
(99.7 %id)
AW162810 brain, frontal lobe .b 5 to 99 1 to 95       95/95
(100 %)
1 diff
(99.0 %id)
AW162703 brain, frontal lobe .b 722 to 1199 495 to 18   tiling clone, AAA   478/478
(100 %)
1 diff
(99.8 %id)
AV750044 Pituitary .c 1 to 426 1 to 416   tiling clone,   416/495
(84 %)
9 diff
(98.2 %id)
BM558383 amelanotic melanoma, cell line, skin .c 2 to 384 1 to 388       388/1403
(27 %)
5 diff
(99.7 %id)
CR604726 B cells (Ramos cell line) Cot 25-normalized .c 5 to 1512 1 to 1508 exact     1508/1508
(100 %)
0 diff
(100 %id)
BI835355 pooled pancreas and spleen .c 13 to 691 1 to 684       684/802
(85 %)
13 diff
(98.4 %id)
TI_57164763   .c 13 to 794 28 to 828       775/829
(93 %)
27 diff
(96.8 %id)
CF127823 Chondrosarcoma Lung Metastasis cell lines, lung .c 31 to 791 1 to 760       760/760
(100 %)
3 diff
(99.7 %id)
TI_154193505   .c 31 to 972 51 to 988       938/1041
(90 %)
15 diff
(98.6 %id)
CR611600 Neuroblastoma Cot 10-normalized .c 40 to 1533 1 to 1494 exact tiling clone,   1494/1494
(100 %)
0 diff
(100 %id)
AL520682 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .c 40 to 743 1 to 704   fully sequenced,   704/704
(100 %)
0 diff
(100 %id)
AL561901 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .c 682 to 1533 852 to 1   fully sequenced,   852/852
(100 %)
6 diff
(99.3 %id)
C15968   .d 1 to 464 1 to 462   tiling clone,   462/462
(100 %)
6 diff
(98.8 %id)
BQ346365 nervous_tumor .d 367 to 778 1 to 411   tiling clone,   411/411
(100 %)
11 diff
(97.4 %id)
BP282416 bone marrow .e 1 to 578 1 to 579 exact tiling clone,   579/581
(99 %)
2 diff
(99.7 %id)
DB133361 thymus .f-u 1 to 569 2 to 570 exact tiling clone, capped   569/569
(100 %)
0 diff
(100 %id)
BX477091   Gene ADPRHL2, variant not shown              
AL559549 T cells from T cell leukemia Gene ADPRHL2, variant not shown       fully sequenced, Suspected internal deletion, suspected internal deletion, this clone was ignored    
AL581146 T cells from T cell leukemia Gene ADPRHL2, variant not shown       fully sequenced, Suspected internal deletion, suspected internal deletion, this clone was ignored    
CA429522 Cell Line, Chondrosarcoma Gene ADPRHL2, variant not shown       AAA Suspected internal deletion, this clone was ignored    
CB268534 adipose Gene ADPRHL2, variant not shown         This clone was ignored    
DA974680 synovial membrane tissue from rheumatioidarthritis Gene ADPRHL2, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB494373 hypothalamus Gene ADPRHL2, variant not shown              
DB565416 hypothalamus Gene ADPRHL2, variant not shown         Submitted on the opposite strand    
AK316349 synovial membrane tissue from rheumatoidarthritis Gene ADPRHL2, variant not shown         Suspected internal deletion, this clone was ignored    
DC326985 caudate nucleus Gene ADPRHL2, variant not shown         Suspected internal deletion, this clone was ignored    
DB360813 mammary gland Gene ADPRHL2, variant not shown              
DA646166 mammary gland Gene ADPRHL2, variant not shown       capped      
AK295283 caudate nucleus Gene ADPRHL2, variant not shown         Suspected internal deletion, this clone was ignored    
DA084970 cerebellum Gene ADPRHL2, variant not shown       capped      
BI912221 leukocyte Gene ADPRHL2, variant not shown              
BM550782 amelanotic melanoma, cell line, skin Gene ADPRHL2, variant not shown         Suspected internal deletion, this clone was ignored    
TI_57236231   Gene ADPRHL2, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI